ArticleAnnals of the rheumatic diseases2009

Inhibition of tumour necrosis factor and IL-17 production by leflunomide involves the JAK/STAT pathway.

I González-Alvaro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.